Biotech · Private company
Edgewood Oncology Inc.
Track this companyFree. Adds Edgewood Oncology Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AzacitidinePhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- BTX-A51Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- BTX-A51Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- BTX-A51 in Patients With Liposarcoma or CIC-rearranged SarcomaPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 30, 2024ClinicalTrials.gov NCT06414434 · fetched Nov 12, 2026
- A Study of BTX-A51 in People With Advanced Solid Tumor and Breast CancerPHASE1 · RECRUITING · started Jun 7, 2021ClinicalTrials.gov NCT04872166 · fetched Nov 12, 2026
- A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromePHASE1 · RECRUITING · started Jan 6, 2020ClinicalTrials.gov NCT04243785 · fetched Nov 12, 2026